Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting the acetylation signaling pathway in cancer therapy

Seminars in Cancer Biology(2021)10.1016/j.semcancer.2021.03.001Source: DataRank Database

Targeting the acetylation signaling pathway in cancer therapy is a research paper published in Seminars in Cancer Biology (2021). On theSindex it has a DataRank of 0. It has been cited 104 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access104 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.98)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Wenyi Wei ORCID,Fabin Dang ORCID

Live enrichment

PubMed:33705871 PMC:PMC8423867 OpenAlex:https://openalex.org/W3133766777

National Institutes of Health

Grant: R01CA177910

NCI NIH HHS

Grant: R01 CA200651

NCI NIH HHS

Grant: R35 CA253027

NCI NIH HHS

Grant: R01 CA229307

NCI NIH HHS

Grant: R35 CA253097

NCI NIH HHS

Grant: K99 CA263194

FWCI

3.98

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8423867

publisherhttps://api.elsevier.com/content/article/PII:S1044579X21000511?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044579X21000511?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.semcancer.2021.03.001

Fields of Study

Histone Deacetylase Inhibitors ResearchSirtuins and Resveratrol in MedicineUbiquitin and proteasome pathwaysHumansAcetylationHistone Deacetylase InhibitorsHistone DeacetylasesProtein Processing, Post-TranslationalNeoplasmsProteinsSignal TransductionCarcinogenesis

MeSH Terms

AcetylationHistone DeacetylasesHumansNeoplasmsProtein Processing, Post-TranslationalProteinsSignal TransductionHistone Deacetylase InhibitorsCarcinogenesis

Keywords

AcetylationHistone AcetyltransferasesHistoneHDAC4SAP30BiologyCarcinogenesisLysineCell biologyChemistryCancer researchBiochemistryHistone H2AGeneAmino acidTumorigenesisCell signalingDeacetylase InhibitorDeacetylaseAcetyl Transferase

Sustainable Development Goals

SDG 0: Good health and well-being